Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 0 | 0 | 0 | 3,923 | 8,038 |
| Gross Profit | N/A | N/A | N/A | 3,923 | 8,038 |
| Operating Expenses | 66,893 | 64,927 | 51,017 | 45,838 | 41,564 |
| Operating Income | -66,893 | -64,927 | -51,017 | -41,915 | -33,526 |
| Other Income | 15,072 | 12,155 | 11,445 | 7,960 | 6,086 |
| Pre-tax Income | -51,821 | -52,772 | -39,572 | -33,955 | -27,440 |
| Net Income Continuous | -51,821 | -52,772 | -39,572 | -33,955 | -27,440 |
| Net Income | $-51,821 | $-52,772 | $-39,572 | $-33,955 | $-27,440 |
| EPS Basic Total Ops | -0.60 | -0.68 | -0.53 | -0.51 | -0.46 |
| EPS Basic Continuous Ops | -0.60 | -0.68 | -0.53 | -0.52 | -0.46 |
| EPS Diluted Total Ops | -0.60 | -0.68 | -0.53 | -0.51 | -0.46 |
| EPS Diluted Continuous Ops | -0.60 | -0.68 | -0.53 | -0.52 | -0.46 |
| EPS Diluted Before Non-Recurring Items | -0.60 | -0.68 | -0.53 | N/A | N/A |
| EBITDA(a) | $-71,244 | $-70,470 | $-56,249 | $-44,767 | $-35,315 |